ATE458487T1 - Tumorbehandlung mit gliotoxin-derivaten - Google Patents
Tumorbehandlung mit gliotoxin-derivatenInfo
- Publication number
- ATE458487T1 ATE458487T1 AT06760774T AT06760774T ATE458487T1 AT E458487 T1 ATE458487 T1 AT E458487T1 AT 06760774 T AT06760774 T AT 06760774T AT 06760774 T AT06760774 T AT 06760774T AT E458487 T1 ATE458487 T1 AT E458487T1
- Authority
- AT
- Austria
- Prior art keywords
- tumor treatment
- gliotoxin
- derivatives
- gliotoxin derivatives
- tumours
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/548—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0104405A AT502055B1 (de) | 2005-06-21 | 2005-06-21 | Anti tumor medikament |
PCT/AT2006/000253 WO2006135949A2 (en) | 2005-06-21 | 2006-06-21 | Tumour treatment with gliotoxin derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE458487T1 true ATE458487T1 (de) | 2010-03-15 |
Family
ID=37102560
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0104405A AT502055B1 (de) | 2005-06-21 | 2005-06-21 | Anti tumor medikament |
AT06760774T ATE458487T1 (de) | 2005-06-21 | 2006-06-21 | Tumorbehandlung mit gliotoxin-derivaten |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0104405A AT502055B1 (de) | 2005-06-21 | 2005-06-21 | Anti tumor medikament |
Country Status (7)
Country | Link |
---|---|
US (1) | US7981878B2 (de) |
EP (1) | EP1901750B1 (de) |
AT (2) | AT502055B1 (de) |
AU (1) | AU2006261566A1 (de) |
CA (1) | CA2612770A1 (de) |
DE (1) | DE602006012487D1 (de) |
WO (1) | WO2006135949A2 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120219568A1 (en) * | 2011-02-24 | 2012-08-30 | Zhejiang University | Epidithiodioxopiprazines and uses thereof in treating cancer |
WO2012177647A2 (en) | 2011-06-20 | 2012-12-27 | Kerry Lane | Mycotoxin diagnostics and methods thereof |
SG11201401287SA (en) | 2011-10-05 | 2014-05-29 | Genentech Inc | Methods of treating liver conditions using notch2 antagonists |
US9765090B2 (en) | 2011-11-25 | 2017-09-19 | Ewha University-Industry Collaboration Foundation | Epidithiodioxopiperazine compound or its derivatives, and the use thereof |
CN104520328B (zh) | 2012-08-13 | 2019-06-07 | 霍夫曼-拉罗奇有限公司 | 抗锯齿蛋白抗体及使用方法 |
WO2014141064A1 (en) | 2013-03-13 | 2014-09-18 | Novartis Ag | Notch2 binding molecules for treating respiratory diseases |
SG10201706210WA (en) | 2013-03-15 | 2017-09-28 | Genentech Inc | Compositions and methods for diagnosis and treatment of hepatic cancers |
WO2014189343A1 (en) * | 2013-05-24 | 2014-11-27 | Ewha University - Industry Collaboration Foundation | Epidithiodioxopiperazine compound or its derivatives, and the use thereof |
MX2016010433A (es) | 2014-02-12 | 2016-09-22 | Genentech Inc | Anticuerpos anti-jagged1 y metodos de uso. |
EP3282019A1 (de) | 2016-08-09 | 2018-02-14 | Medizinische Universität Wien | Genotypisierung und behandlung von krebs, insbesondere chronischer lymphozytischer leukämie |
KR102091730B1 (ko) * | 2017-07-05 | 2020-03-23 | 바스테라 주식회사 | 에피디티오디옥소피페라진 화합물 또는 이의 유도체, 또는 이들의 약학적으로 허용가능한 염을 포함하는 폐동맥고혈압 예방 또는 치료용 약학적 조성물 |
US20220323453A1 (en) * | 2019-08-28 | 2022-10-13 | Vasthera Co. Ltd. | Pharmaceutical composition for prevention or treatment of solid cancer comprising epidithiodioxopiperazine derivative or pharmaceutically acceptable salt thereof |
CN116286897B (zh) * | 2023-03-29 | 2024-05-03 | 佛山科学技术学院 | 一种编码酰基转移酶的Tri3基因及其应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ212051A (en) | 1984-05-18 | 1988-10-28 | Univ Australian | Immune response suppression; certain epipolythio- dioxopiperazine derivatives and their preparation |
JPS61277617A (ja) | 1985-05-31 | 1986-12-08 | Yakult Honsha Co Ltd | 坑血小板凝集剤 |
WO1992010198A1 (en) * | 1990-12-06 | 1992-06-25 | Johnson & Johnson Research Pty Limited | Immunotherapeutic agents, compositions and methods |
JP2801491B2 (ja) | 1993-01-26 | 1998-09-21 | 敦 沼田 | エピポリチオジオキソピペラジン誘導体およびその製造法 |
JP3498925B2 (ja) | 1994-02-18 | 2004-02-23 | 日本肥糧株式会社 | グリオクラディウム・ビレンスによるグリオトキシンの生産方法 |
CN1215433A (zh) * | 1996-12-02 | 1999-04-28 | 味之素株式会社 | 胶霉毒素衍生物及由它制成的抗癌药 |
US6703221B1 (en) * | 1999-08-19 | 2004-03-09 | Chiron Corporation | Notch receptor ligands and uses thereof |
US20040101847A1 (en) * | 2002-11-22 | 2004-05-27 | Isis Pharmaceuticals Inc. | Modulation of Notch2 expression |
US20040001847A1 (en) | 2002-06-26 | 2004-01-01 | Lasalvia-Prisco Eduardo M. | Method and composition to elicit an effective autologous antitumoral immune response in a patient |
US20050191302A1 (en) | 2002-08-29 | 2005-09-01 | University Of Southampton | Treatment for liver disease |
-
2005
- 2005-06-21 AT AT0104405A patent/AT502055B1/de not_active IP Right Cessation
-
2006
- 2006-06-21 AT AT06760774T patent/ATE458487T1/de not_active IP Right Cessation
- 2006-06-21 AU AU2006261566A patent/AU2006261566A1/en not_active Abandoned
- 2006-06-21 WO PCT/AT2006/000253 patent/WO2006135949A2/en active Application Filing
- 2006-06-21 US US11/993,804 patent/US7981878B2/en not_active Expired - Fee Related
- 2006-06-21 CA CA002612770A patent/CA2612770A1/en not_active Abandoned
- 2006-06-21 EP EP06760774A patent/EP1901750B1/de not_active Not-in-force
- 2006-06-21 DE DE602006012487T patent/DE602006012487D1/de active Active
Also Published As
Publication number | Publication date |
---|---|
AU2006261566A1 (en) | 2006-12-28 |
WO2006135949A2 (en) | 2006-12-28 |
CA2612770A1 (en) | 2006-12-28 |
AT502055B1 (de) | 2007-11-15 |
US7981878B2 (en) | 2011-07-19 |
EP1901750A2 (de) | 2008-03-26 |
DE602006012487D1 (de) | 2010-04-08 |
EP1901750B1 (de) | 2010-02-24 |
US20090029974A1 (en) | 2009-01-29 |
WO2006135949A3 (en) | 2007-07-05 |
AT502055A1 (de) | 2007-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE458487T1 (de) | Tumorbehandlung mit gliotoxin-derivaten | |
NL301089I2 (nl) | imlifidase | |
EA201170872A1 (ru) | Ингибиторы протеинкиназы | |
EA200971068A1 (ru) | Триазолиламинопиримидиновые соединения | |
CY1118523T1 (el) | Πεπτιδικες ενωσεις για την θεραπεια του ανθεκτικου status epilepticus | |
EA200801428A1 (ru) | Производные пиридиазинона для лечения опухолей | |
NO20091661L (no) | Anvendelse av pegylert IL-10 for a behandle kreft | |
EA200970935A1 (ru) | Способы лечения с применением хинаксолиновых ингибиторов pi3k-альфа | |
MY148491A (en) | FUSED BICYCLIC mTOR INHIBITORS | |
EA201690265A2 (ru) | Фармацевтические композиции, содержащие замещенные ациланилиды | |
CY1116645T1 (el) | Ενωση-αναστολεας σηματοδοτικου μονοπατιου notch | |
EA201171367A1 (ru) | Винилиндазолильные соединения | |
EA201170252A1 (ru) | Амидофеноксиндазолы в качестве ингибиторов c-мет | |
EA200900798A1 (ru) | Производные индол-4-илпиримидинил-2-иламина и их применение в качестве ингибиторов циклинзависимой киназы | |
EA201270049A1 (ru) | Дизамещенные фталазиновые антагонисты пути hedgehog | |
CL2008001705A1 (es) | Compuestos derivados de heterociclos de nitrogeno; y uso del compuesto para el tratamiento de enfermedades o trastornos relacionados con el receptor de histamina h3. | |
MX2009008347A (es) | Oxabicicloheptanos y oxabicicloheptenos, su preparacion y uso. | |
CL2007002382A1 (es) | Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento del cancer a la piel. | |
TW200745043A (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
WO2007016338A3 (en) | Use of chk2 kinase inhibitors for cancer treatment | |
TW200738699A (en) | 4-Substituted pyrazoline compounds, their preparation and use as medicaments | |
AR061446A1 (es) | Utilizacion de la 1,7 -dimetilxantina para la fabricacion de un medicamento psicoanaleptico no ansiogeno destinado al tratamiento de un trastorno neuropsiquiatrico | |
BRPI0818170A2 (pt) | 5-cianotienopiridinas para o tratamento de tumores. | |
EA200801425A1 (ru) | Диазепиноны | |
EA201170344A1 (ru) | Азаиндольные ингибиторы iap |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |